Abstract
Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 190-192 |
| Number of pages | 3 |
| Journal | Journal of the European Academy of Dermatology and Venereology |
| Volume | 17 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 1 2003 |
| Externally published | Yes |
Keywords
- 5-fluorouracil
- Actinic keratosis
- Chemotherapy
- Porokeratosis
ASJC Scopus subject areas
- Dermatology
- Infectious Diseases
Fingerprint Dive into the research topics of 'Systemic 5-fluorouracil producing an inflammatory response in porokeratosis'. Together they form a unique fingerprint.
Cite this
Nahm, W. K., Donohue, K. G., Danahy, J. F., Badiavas, E., & Falanga, V. (2003). Systemic 5-fluorouracil producing an inflammatory response in porokeratosis. Journal of the European Academy of Dermatology and Venereology, 17(2), 190-192. https://doi.org/10.1046/j.1468-3083.2003.00575.x